CAS 885101-89-3
:Acido 3-{4-[(3-fenossibenzil)ammino]fenil}propanoico
- Benzenepropanoic acid, 4-[[(3-phenoxyphenyl)methyl]amino]-
- Gw9508
3-(4-{[(3-Phenoxyphenyl)methyl]amino}phenyl)propanoic acid
CAS:3-(4-{[(3-Phenoxyphenyl)methyl]amino}phenyl)propanoic acidPurezza:98%Peso molecolare:347.40704g/molGW9508
CAS:GW9508(GW 9508) is a potent and selective agonist for FFA1 (GPR40), stimulates insulin secretion in a glucose-sensitive manner.
Formula:C22H21NO3Purezza:97.89% - 99.19%Colore e forma:SolidPeso molecolare:347.413-(4-((3-Phenoxybenzyl)amino)phenyl)propanoic acid
CAS:Purezza:95.0%Colore e forma:SolidPeso molecolare:347.41400146484375Ref: 10-F221962
1gPrezzo su richiesta10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta250mgPrezzo su richiestaGW9508
CAS:Prodotto controllatoApplications GW9508 is a GPR40 full agonist, used to regulate glucose in rats. Can be applied to the treatment of diabetes type 2. GPR120 selective and potent agonist also used in the treatment of diabetes type 2 due to GPR120’s ability to mediate GLP-1 secretion, insulin sensitization and anti-obesity effects.
References Luo, J. et al.: PLoS One., 7, 46300 (2012); Shimpukade, B. et al.: J. Med. Chem., 55, 4511 (2012);Formula:C22H21NO3Colore e forma:NeatPeso molecolare:347.41GPR40 Agonist
CAS:GW9508 is a GPR40 agonist that activates the receptor and increases cytosolic calcium. It has been shown to increase glucose uptake in pluripotent cells and decrease glucose production by decreasing the activity of gluconeogenic enzymes. GW9508 is also a potential drug for diabetes as it can stimulate insulin secretion. This drug has been shown to activate toll-like receptors, which are proteins that sense microbial infections and regulate inflammatory responses. It may also act as an agonist for other receptors such as DPP-IV inhibitors or response elements.
Formula:C22H21NO3Purezza:Min. 95%Peso molecolare:347.41 g/mol





